EPIDEMIOLOGIJA RAKA PANKREASA

  • Belma Muratović Medicinski fakultet, Univerzitet u Beogradu, Beograd, Republika Srbija
  • Aleksandra Nikolić Institut za epidemiologiju, Medicinski fakultet, Univerzitet u Beogradu, Beograd, Republika Srbija
Ključne reči: rak pankreasa, incidencija, mortalitet, faktori rizika, preživljavanje, prevencija

Sažetak


U svetu, rak pankreasa je sedmi vodeći uzrok umiranja i dvanaesti vodeći uzrok obolevanja medju svim malignim tumorima. Stope incidencije i mortaliteta variraraju od zemlje do zemlje, što je posledica izloženosti različitim faktorima rizika, mogućnostima ranog dijagnostikovanja i pravovremenog i adekvatnog lečenja. Procenjuje se da će do 2040. godine doći do daljeg porasta broja obolelih (npr. za 27,4% u Evropi) i umrlih (npr. za 28,5% u Evropi) od karcinoma pankreasa. Prema Nacionalnom institutu za karcinome u Sjedinjenim Američkim Državama prosečno petogodišnje preživljavanje za rak pankreasa iznosi 12%. Promenljivi i nepromenljivi faktori doprinose nastanku ovog tumora. Rak pankreasa se češće javlja kod starijih, muškaraca, korisnika duvana i alkohola, osoba sa dijabetesom, preležanim pankreatitisom, fizički neaktivnih i gojaznih, kao i kod osoba sa pozitivnom porodičnom anamnezom za ovaj maligni tumor. Neophodno je raditi na edukaciji stanovništva o faktorima rizika za nastanak raka pankreasa, mogućnostima prevencije i načinu ranog dijagnostikovanja ove bolest.

Reference

Cancer today [Internet]. [ciInstitut za epidemiologiju, Medicinski fakultet, Univerzitet u Beogradu, Beograd, Republika Srbijated 2023 Nov 2]. Available from: http://gco.iarc.fr/today/home

Rawla P, Sunkara T, Gaduputi V. Epidemiology of Pancreatic Cancer: Global Trends, Etiology and Risk Factors. World J Oncol. 2019;10(1):10–27.

Bosetti C, Levi F, Ferlay J, Garavello W, Lucchini F, Bertuccio P, et al. Trends in oesophageal cancer incidence and mortality in Europe. Int J Cancer. 2007;122(5):1118–29.

Klein AP, Brune KA, Petersen GM, Goggins M, Tersmette AC, Offerhaus GJA, et al. Prospective Risk of Pancreatic Cancer in Familial Pancreatic Cancer Kindreds. Cancer Research. 2004;64(7):2634–8.

Hidalgo M, Cascinu S, Kleeff J, Labianca R, Löhr JM, Neoptolemos J, et al. Addressing the challenges of pancreatic cancer: future directions for improving outcomes. Pancreatology. 2015;15(1):8–18.

SEER [Internet]. [cited 2023 Nov 3]. Cancer of the Pancreas - Cancer Stat Facts. Available from: https://seer.cancer.gov/statfacts/html/pancreas.html

Zhang L, Sanagapalli S, Stoita A. Challenges in diagnosis of pancreatic cancer. World J Gastroenterol. 2018;24(19):2047–60.

Mohammed S, Van Buren II G, Fisher WE. Pancreatic cancer: Advances in treatment. World J Gastroenterol. 2014;20(28):9354–60.

MaligniTumoriuRepubliciSrbiji2020.pdf [Internet]. [cited 2023 Nov 2]. Available from: https://www.batut.org.rs/download/publikacije/MaligniTumoriuRepubliciSrbiji2020.pdf

Ezzati M, Henley SJ, Lopez AD, Thun MJ. Role of smoking in global and regional cancer epidemiology: Current patterns and data needs. International Journal of Cancer. 2005;116(6):963–71.

Mathers CD, Fat DM, Inoue M, Rao C, Lopez AD. Counting the dead and what they died from: an assessment of the global status of cause of death data. Bull World Health Organ. 2005;83(3):171–7.

Muratović B, Nikolić A, Šipetić-Grujičić S. Trends in incidence and mortality from pancreatic cancer in Central Serbia, in the period from 1999 to 2019. Zdravstvena zaštita. 2022;51(1):23–38.

Oberstein PE, Olive KP. Pancreatic cancer: why is it so hard to treat? Therapy Adv Gastroenterol. 2013;6(4):321–37.

Cancer Tomorrow [Internet]. [cited 2023 Nov 2]. Available from: https://gco.iarc.fr/tomorrow/en/dataviz/bars?types=0&sexes=0&mode=population&group_populations=0&multiple_populations=1&multiple_cancers=0&cancers=13&populations=903_904_905_908_909_935&single_unit=100

Lucenteforte E, La Vecchia C, Silverman D, Petersen GM, Bracci PM, Ji BT, et al. Alcohol consumption and pancreatic cancer: a pooled analysis in the International Pancreatic Cancer Case–Control Consortium (PanC4). Ann Oncol. 2012;23(2):374–82.

Arslan AA, Helzlsouer KJ, Kooperberg C, Shu XO, Steplowski E, Bueno-de-Mesquita HB, et al. Anthropometric Measures, Body Mass Index and Pancreatic Cancer: a Pooled Analysis from the Pancreatic Cancer Cohort Consortium (PanScan). Arch Intern Med. 2010;170(9):791–802.

Larsson SC, Wolk A. Red and processed meat consumption and risk of pancreatic cancer: meta-analysis of prospective studies. Br J Cancer. 2012;106(3):603–7.

Appleby PN, Crowe FL, Bradbury KE, Travis RC, Key TJ. Mortality in vegetarians and comparable nonvegetarians in the United Kingdom123. Am J Clin Nutr. 2016;103(1):218–30.

Maisonneuve P, Lowenfels AB. Risk factors for pancreatic cancer: a summary review of meta-analytical studies. International Journal of Epidemiology. 2015;44(1):186–98.

Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians. 2018;68(6):394–424.

Hu JX, Zhao CF, Chen WB, Liu QC, Li QW, Lin YY, et al. Pancreatic cancer: A review of epidemiology, trend, and risk factors. WJG. 2021;27(27):4298–321.

Lucas AL, Kastrinos F. Screening for Pancreatic Cancer. JAMA. 2019;322(5):407–8.

Kuroczycki-Saniutycz S, Grzeszczuk A, Zwierz ZW, Kołodziejczyk P, Szczesiul J, Zalewska-Szajda B, et al. Prevention of pancreatic cancer. Contemp Oncol (Pozn). 2017;21(1):30–4.

Objavljeno
2023/12/14
Rubrika
Pregledni rad